Clinical Trials

» COLON CANCER
» BLADDER CANCER
» HEAD & NECK CANCER
» BREAST CANCER
» LUNG CANCER
» BLOOD DISORDER
» PROSTATE CANCER

COLON CANCER

E5202 Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
(Project 823)
Eric Bravin, M.D.

Trial Contact Information:
Kathleen Kasprowicz, C.C.R.P. kathleen.kasprowicz@bassett.org 607-547-3073
Kathleen Leonardo, R.N., M.S.N. kathleen.leonardo@bassett.org 607-547-6373

N0147 Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer
(Project 855)
Eric Bravin, M.D.

Trial Contact Information:
Kathleen Kasprowicz, C.C.R.P. kathleen.kasprowicz@bassett.org 607-547-3073
Kathleen Leonardo, R.N., M.S.N. kathleen.leonardo@bassett.org 607-547-6373

BLADDER CANCER

VINCENT CA183002 First-Line Treatment of Advanced Bladder Cancer Randomized vs. Gemcitabine ± Vinflunine in Patients Ineligible to Receive Cisplatin-Based Therapy
(Project 848)
James Leonardo, M.D., Ph.D.

Trial Contact Information:
Kathleen Kasprowicz, C.C.R.P. kathleen.kasprowicz@bassett.org 607-547-3073
Kathleen Leonardo, R.N., M.S.N. kathleen.leonardo@bassett.org 607-547-6373

HEAD & NECK CANCER

E1302 Docetaxel With or Without Gefitinib in Treating Patients With Metastatic or Locally Recurrent Head and Neck Cancer
(Project 774)
Eric Bravin, M.D.

Trial Contact Information:
Kathleen Kasprowicz, C.C.R.P. kathleen.kasprowicz@bassett.org 607-547-3073
Kathleen Leonardo, R.N., M.S.N. kathleen.leonardo@bassett.org 607-547-6373

BREAST CANCER

A6181094 Study Of Sunitinib Plus Paclitaxel Versus Bevacizumab Plus Paclitaxel In Patients With Advanced Breast Cancer
(Project 867)
Eric Bravin, M.D.

Trial Contact Information:
Kathleen Kasprowicz, C.C.R.P. kathleen.kasprowicz@bassett.org 607-547-3073
Kathleen Leonardo, R.N., M.S.N. kathleen.leonardo@bassett.org 607-547-6373

NSABP B-39 Radiation Therapy Study of Whole Breast Versus Partial Breast Irradiation in Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer
(Project 850)
Phillip Purser, M.D.

Trial Contact Information:
Kathleen Kasprowicz, C.C.R.P. kathleen.kasprowicz@bassett.org 607-547-3073
Kathleen Leonardo, R.N., M.S.N. kathleen.leonardo@bassett.org 607-547-6373

TAILORx (PACCT-1) Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer
(Project 834)
Eric Bravin, M.D.

Trial Contact Information:
Kathleen Kasprowicz, C.C.R.P. kathleen.kasprowicz@bassett.org 607-547-3073
Kathleen Leonardo, R.N., M.S.N. kathleen.leonardo@bassett.org 607-547-6373

ASOSOG Z1031 Exemestane, Letrozole, or Anastrozole in Treating Postmenopausal Women Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer
(Project 839)
Bernadette Ryan, M.D.

Trial Contact Information:
Kathleen Kasprowicz, C.C.R.P. kathleen.kasprowicz@bassett.org 607-547-3073
Kathleen Leonardo, R.N., M.S.N. kathleen.leonardo@bassett.org 607-547-6373

LUNG CANCER

AVF 3671g A Study Comparing Bevacizumab Therapy With or Without Erlotinib for First-Line Treatment of Non-Small Cell Lung Cancer (ATLAS)
(Project 842)
Eric Bravin, M.D.

Trial Contact Information:
Kathleen Kasprowicz, C.C.R.P. kathleen.kasprowicz@bassett.org 607-547-3073
Kathleen Leonardo, R.N., M.S.N. kathleen.leonardo@bassett.org 607-547-6373

E1505 Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
(Project 877)
Eric Bravin, M.D.

Trial Contact Information:
Kathleen Kasprowicz, C.C.R.P. kathleen.kasprowicz@bassett.org 607-547-3073
Kathleen Leonardo, R.N., M.S.N. kathleen.leonardo@bassett.org 607-547-6373

BLOOD DISORDER

S0325 Imatinib Mesylate or Dasatinib in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia
(Project 741)
Eric Bravin, M.D.

Trial Contact Information:
Kathleen Kasprowicz, C.C.R.P. kathleen.kasprowicz@bassett.org 607-547-3073
Kathleen Leonardo, R.N., M.S.N. kathleen.leonardo@bassett.org 607-547-6373

E1A05 Bortezomib and Dexamethasone With or Without Lenalidomide in Treating Patients With Multiple Myeloma Previously Treated With Dexamethasone
Eric Bravin, M.D.

Trial Contact Information:
Kathleen Kasprowicz, C.C.R.P. kathleen.kasprowicz@bassett.org 607-547-3073
Kathleen Leonardo, R.N., M.S.N. kathleen.leonardo@bassett.org 607-547-6373

PROSTATE CANCER

RTOG 0521 Hormone Therapy and Radiation Therapy or Hormone Therapy and Radiation Therapy Followed by Docetaxel and Prednisone in Treating Patients With Localized Prostate Cancer
(Project 868)
Phillip Purser, M.D.

Trial Contact Information:
Kathleen Kasprowicz, C.C.R.P. kathleen.kasprowicz@bassett.org 607-547-3073
Kathleen Leonardo, R.N., M.S.N. kathleen.leonardo@bassett.org 607-547-6373